Correction: Measuring Atrioventricular Valve Regurgitation Using 4D Flow Cardiovascular Magnetic Resonance Post-Fontan

• by Husayn M. Ladha, Justin C. Wang, Yu Li, Adam B. Christopher, Jacqueline Kreutzer, Rajesh Krishnamurthy, Francesca Raimondi, Joshua D. Robinson, Yue-Hin Loke, Laura J. Olivieri, Mark A. Fogel, Rafael Ceschin, Rahul H. Rathod, Tarek Alsaied

• July 15, 2026

AD Not Linked to Early CV Risk Markers

Repeated assessments from childhood to early adulthood did not identify consistent cardiometabolic risk patterns by disease activity or severity.

• by Kathryn Wighton

• May 27, 2026

• 5 min

Case Report: The effect of early initiation of eteplirsen treatment on the cardiac and motor disease course in an individual with Duchenne muscular dystrophy

• by Yamen Masalha, Yoav Zehavi, Banan Musallam, Majd Khamaysi, Maali Abu Omer, Daniel L. Fink, Ronen Spiegel

• July 9, 2026

When Bad Data Enters the Drug Pipeline

Federal prosecutors allege that a Florida physician and research staff fabricated clinical trial records that were submitted into database systems used to evaluate investigational drugs.

• by Kathryn Wighton

• June 11, 2026

• 2 min